Indivior (LON:INDV) Trading Down 1.2% – Should You Sell?

Indivior PLC (LON:INDV) shares traded down 1.2% on Wednesday . The stock traded as low as GBX 891 ($11.25) and last traded at GBX 897 ($11.32). 215,905 shares changed hands during trading, a decline of 81% from the average session volume of 1,137,238 shares. The stock had previously closed at GBX 908 ($11.46).

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,500 ($18.93) price objective on shares of Indivior in a report on Thursday, September 5th.

Indivior Stock Performance

The company’s 50 day simple moving average is GBX 765.53 and its 200 day simple moving average is GBX 926.53. The company has a debt-to-equity ratio of 2,790.00, a quick ratio of 1.52 and a current ratio of 0.85. The stock has a market cap of £1.17 billion, a PE ratio of -1,135.00, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.